The expression of TJP-2 has also been found to be downregulated in various carcinomas, such as breast [51,52] and pancreatic [53] as well as in hypoxia-resistant cancer cell lines derived from scirrhous gastric carcinoma [54]. Here, TJP2 is linked to cancer.